Loading...

Pfizer Vaccine for Kids May Not Be Available Until November

September 29, 2021by Jonathan Lemire, Associated Press
Pfizer Vaccine for Kids May Not Be Available Until November
A certified medical assistant prepares doses of the Pfizer COVID-19 vaccine at a vaccination center at the University of Nevada, Las Vegas. (AP Photo/John Locher)

WASHINGTON (AP) — Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November.

The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old. Officials had said previously they would file an application with the FDA to authorize use in the coming weeks.

Once the company files its application, U.S. regulators and public health officials will review the evidence and consult with their advisory committees in public meetings to determine if the shots are safe and effective enough to recommend use. 

That process may mean the shots may not be available until closer to Thanksgiving, according to a person familiar with the process but not authorized to discuss it publicly. But it is possible that, depending on how quickly the FDA acts, the shots could become available earlier in November, the person said.

The drugmaker and its partner, Germany’s BioNTech, say they expect to request emergency use authorization of their vaccine in children ages 5 to 11 “in the coming weeks.” The companies also plan to submit data to the European Medicines Agency and other regulators.

The two-shot Pfizer vaccine is currently available for those 12 and older. An estimated 100 million people in the U.S. have been fully vaccinated with it, according to the Centers for Disease Control and Prevention.

Pfizer tested a lower dose of the shots in children. The drugmaker said last week that researchers found the vaccine developed coronavirus-fighting antibody levels in children that were just as strong as those found in teenagers and young adults getting regular-strength doses.

Earlier this month, FDA chief Dr. Peter Marks told the AP that once Pfizer turns over its study results, his agency would evaluate the data “hopefully in a matter of weeks” to decide if the shots are safe and effective enough for younger kids.

Pfizer’s updated timetable was first reported by The Wall Street Journal.

Another U.S. vaccine maker, Moderna, also is studying its shots in elementary school-aged children. Results are expected later in the year.

In The News

Health

Voting

Health

US Jobless Claims Rise to 286,000, Highest Since October

WASHINGTON (AP) — The number of Americans applying for unemployment benefits rose to the highest level in three months as... Read More

WASHINGTON (AP) — The number of Americans applying for unemployment benefits rose to the highest level in three months as the fast-spreading omicron variant continued to disrupt the job market. Jobless claims rose for the third straight week — by 55,000 to 286,000, highest since mid-October,... Read More

January 19, 2022
by Alexa Hornbeck
Survey Reveals New Findings About Drug Affordability

A survey was released yesterday by the Office of the Assistant Secretary for Planning and Evaluation that uses National Health Interview Survey... Read More

A survey was released yesterday by the Office of the Assistant Secretary for Planning and Evaluation that uses National Health Interview Survey data to estimate that 3.5 million adults 65 and older had trouble paying for medications in 2019. According to the survey, more than 5 million Medicare... Read More

January 19, 2022
by Alexa Hornbeck
CBO Releases Report on Nationwide Spending on Prescription Drugs

The Congressional Budget Office released a report this week that examines trends in nationwide spending on prescription drugs over the 1980-2018... Read More

The Congressional Budget Office released a report this week that examines trends in nationwide spending on prescription drugs over the 1980-2018 period and provides a detailed analysis of trends in spending, use and prices in the Medicare Part D and Medicaid programs over the 2009-2018 period.  The... Read More

January 19, 2022
by Alexa Hornbeck
Biden Will Provide Free, High-Quality Masks to Americans

On Wednesday, the Biden administration announced plans to provide 400 million free high-quality N95 masks to Americans starting next week.... Read More

On Wednesday, the Biden administration announced plans to provide 400 million free high-quality N95 masks to Americans starting next week. According to a White House official, the effort is the largest deployment of personal protective equipment in U.S. history.  The masks will come from the Strategic... Read More

January 19, 2022
by Alexa Hornbeck
Study Shows Herpes-Related Virus May Cause Multiple Sclerosis

A recent study finds that the Epstein-Barr virus, a member of the herpes virus family, is likely what causes multiple sclerosis. MS... Read More

A recent study finds that the Epstein-Barr virus, a member of the herpes virus family, is likely what causes multiple sclerosis. MS is a progressive disease that affects the central nervous system of 2.8 million people worldwide, but for a long time its etiology has been unknown. To... Read More

January 19, 2022
by Alexa Hornbeck
Kaiser Mental Health Physicians Strike, Demand Culturally Competent Care

On Monday, according to information from the National Union of Healthcare Workers, nearly 200 mental health clinicians from Kaiser Permanente,... Read More

On Monday, according to information from the National Union of Healthcare Workers, nearly 200 mental health clinicians from Kaiser Permanente, a major health care company, took to the streets of Oakland, California, with demands for more culturally responsive care for communities of color. The strike was... Read More

News From The Well
Exit mobile version